2018
Patients with amnestic mild cognitive impairment (aMCI) are heterogeneous as regard to their amyloid status. The present study aimed at (…)
Consulter 
2018
Consulter
2020
Several concepts, which in the aggregate get might be used to account for "resilience" against age- and disease-related changes, have (…)
Consulter
2018
To estimate the prevalence of amyloid positivity, defined by positron emission tomography (PET)/cerebrospinal fluid (CSF) biomarkers and/or neuropathological examination, in (…)
Consulter
2018
In Alzheimer’s disease (AD), pathological changes may arise up to 20 years before the onset of dementia. This pre-dementia window provides (…)
Consulter
2019
Alzheimer’s disease and related dementias (ADRDs) are a global crisis facing the aging population and society as a whole. With (…)
Consulter
